Payers Expect Clearer Demonstration of Health Technology Benefits
Sweden and Finland are leaders in developing and applying health technology and provide ideal environments for conducting Health Technology Assessments (HTA) for medical devices.
Pricing and Reimbursement
We provide assistance to our clients at all stages of the price and reimbursement application process.
Generally, from the patients’ perspective, the market access of an outpatient medicinal product requires that a product is reimbursed through health insurance. Optimally, the new drug will be available to patients in need as quickly and extensively as possible and at a competitive price. The price and reimbursement application process plays an important role in this.
To do this, we provide assistance to our clients at all stages of the price and reimbursement application process. The service is tailored to meet our customer’s needs. We provide assistance to help you through the whole application process, from health economic evaluation and RWE studies to smaller consultation assistance at different stages of application processes.
Our comprehensive pricing and reimbursement services include:
- Providing strategic and tactical counseling in the different phases of the pricing and reimbursement application process
- Preparing and compiling basic and special reimbursement applications for medicinal products containing a new active ingredient, applications for renewal and extension, and applications concerning a new strength, package size and pharmaceutical form
- This also includes the health economic studies required for the application as well as any needed RWE studies
- Providing expert assistance and advice on risk-sharing agreements and contractual arrangements for conditional reimbursement
A typical pricing and reimbursement project
Read more:
For more information on the price and reimbursement process read our article Market access, pricing and reimbursement of medicines in Finland.
Pharmaceuticals Pricing Board – www.hila.fi
Kela – Reimbursement for medicine expenses
Related articles
-
-
Medaffcon’s Patient Dynamics Tool Helps to Focus and Find the Right Actions
Are you employed in the pharmaceutical industry and seeking insights into your product's position within the Finnish market? Then Patient Dynamics is the ideal tool for you. Developed by Medaffcon, Patient Dynamics caters to the needs of pharmaceutical companies by providing precise information for sales and marketing decision-making.
-
Renewable drug therapy challenges the current complex drug evaluation system
“Renewable drug therapy challenges the current complex drug evaluation system,” states Lauri Pelkonen, a leading expert at the Ministry of Social Affairs and Health (STM). For this reason, the evaluation activity is being reformed to better respond to changes in the operating environment.
